1.
Tha├ži D, Armstrong A, Gordon KB, Blauvelt A, Paul C, Boehncke W-H, Wang M, Szilagyi B, Hoepken B, Lambert J, Lebwohl M. Bimekizumab 3-year Maintenance of Response in Week 16 Responders with Moderate to Severe Plaque Psoriasis: Results from Five Phase 3/3b Trials. J of Skin [Internet]. 2024Jan.16 [cited 2024Jul.19];8(1):s306. Available from: https://jofskin.org/index.php/skin/article/view/2452